The Recall Desk

Hazard

Particulate Matter recalls

410 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
410
Critical
57
Severe
186
Most recent
2026-09-02

Of the 410 particulate matter recalls we have scored against our rubric, 57 (14%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 186 (45%) are Severe.

Which agencies issued them

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all particulate matter recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

301–325 of 410

  • SevereFDA (Drugs)·D-1332-2015·2015-08-26

    Mylan Recalls Gemcitabine Injection Vials Due to Particulate Matter

    Mylan Institutional LLC is recalling specific lots of Gemcitabine for Injection due to the presence of particulate matter. The affected vials were distributed nationwide and in Puerto Rico.

    Product
    Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial, Rx only, labeled as a) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-464-20, UPC 3 67457 46420 6; and b) Distributed by Pfizer Labs, Division of Pfize
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1328-2015·2015-08-19

    Methotrexate Injection Recalled Due to Presence of Particulate Matter

    Mylan Institutional LLC is recalling Methotrexate Injection vials due to the presence of particulate matter.

    Product
    Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Ro
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1329-2015·2015-08-19

    Mylan Recalls Cytarabine Injection Vials Due to Particulate Matter

    Mylan Institutional LLC is recalling 8,340 vials of Cytarabine Injection due to the presence of particulate matter. The affected product was distributed nationwide.

    Product
    Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 10 x 5 mL Vials per carton (NDC 0069-0152-02), Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017.
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1211-2015·2015-07-15

    Baxter Recalls Lactated Ringers Bags Due to Metal Particulate Matter

    Baxter Healthcare is recalling specific lots of Lactated Ringers Injection due to the presence of metal particulate matter.

    Product
    LACTATED RINGERS — LACTATED RINGERS (SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE)
    Category
    Drug
    Distribution
    1 state
  • CriticalFDA (Drugs)·D-1210-2015·2015-07-15

    Baxter Recalls 10% Dextrose Injection Bags Due to Metal Particulate Matter

    Baxter Healthcare is recalling 18,324 bags of 10% Dextrose Injection due to the presence of metal particulate matter. The affected products were distributed in the US, Puerto Rico, and Bermuda.

    Product
    DEXTROSE — DEXTROSE (DEXTROSE MONOHYDRATE)
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1089-2015·2015-07-15

    Teva Recalls Adrucil Fluorouracil Injection Due to Particulate Matter

    Teva Pharmaceuticals is recalling Adrucil (fluorouracil injection) vials due to the presence of black particulate matter, including silicone rubber and drug crystals.

    Product
    Adrucil (fluorouracil injection, USP) Pharmacy Bulk Package Not for Direct Infusion, 5 g/100 mL (50 mg/mL), For Intravenous Use Only, Rx Only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-3019-11
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1216-2015·2015-07-15

    Hospira Recalls Bupivacaine Hydrochloride Vials Due to Particulate Matter

    Hospira is recalling Bupivacaine Hydrochloride Injection vials because they contain free-floating and embedded iron oxide particles.

    Product
    BUPIVACAINE HYDROCHLORIDE — BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0976-2015·2015-05-13

    Hospira Recalls 0.9% Sodium Chloride Injection Due to Human Hair

    Hospira Inc. is recalling 9,912 units of 0.9% Sodium Chloride Injection, USP, 250 mL, because human hair was found floating in the IV solution.

    Product
    0.9% Sodium Chloride Injection, USP, 250 mL, Rx only, VisIV Container, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7983-25.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0965-2015·2015-04-29

    SCA Pharmaceuticals Recalls Droperidol Injection Due to Particulate Presence

    SCA Pharmaceuticals is recalling 421 syringes of Droperidol injection because of the presence of particulate matter. The product was distributed in Indiana, Arkansas, Missouri, and Minnesota.

    Product
    Droperidol injection, 2.5 mg/mL, 5 mg Total Dose, 2 mL Fill Volume per syringe, packaged in 10-count syringes per heat sealed bag, RX only; Compounded for Office Use by SCA Pharmaceuticals, Little Rock, AR (877 ) 550-5059 Bar Code 88888-7720-16
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-0969-2015·2015-04-29

    Hospira Recalls 0.9% Sodium Chloride Injection Due to Human Hair Particulate

    Hospira is recalling 0.9% Sodium Chloride Injection, USP, 250 mL, because a human hair was found sealed in the bag at the additive port area.

    Product
    0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-481-2015·2015-04-15

    Baxter Recalls Sodium Chloride Injection Bags Due to Plastic Fragments

    Baxter Healthcare is recalling 542,080 bags of 0.9% Sodium Chloride Injection USP due to confirmed reports of blue plastic fragments from vial adapters.

    Product
    SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0427-2015·2015-04-01

    American Specialty Pharmacy Recalls Hydroxocobalamin Injection Due to Particulate Matter

    American Specialty Pharmacy is recalling 15 vials of Hydroxocobalamin Injection Solution 1 mg/mL due to the presence of particulate matter and potential preservative issues.

    Product
    Hydroxocobalamin Injection Solution 1 mg/mL Inj., Rx, compounded by American Specialty Pharmacy, Plano, TX 75075 214-919-2090. NDC 99999-9994-27
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0394-2015·2015-03-04

    Sun Pharma Recalls Ketorolac Ophthalmic Solution Due to Particulate Matter

    Sun Pharma Global Fze is recalling specific bottles of Ketorolac Tromethamine Ophthalmic Solution because the product contains particulate matter exceeding specification limits.

    Product
    Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 3 mL bottle, Rx only, Distributed by: Caraco Pharmaceutical Laboratories Ltd., 1150 Elijah Mccoy Drive, Detroit, MI 48202; Manufactured at: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; NDC 41
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0391-2015·2015-02-25

    Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter

    Hospira is recalling specific vials of 1% Lidocaine Hydrochloride Injection because a returned sample contained human hair attached to the stopper.

    Product
    LIDOCAINE HYDROCHLORIDE — LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0382-2015·2015-02-11

    Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter

    Hospira Inc. is recalling 120,900 vials of 1% Lidocaine Hydrochloride Injection because iron oxide particulates were found in the solution.

    Product
    LIDOCAINE HYDROCHLORIDE — LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0085-2015·2014-11-12

    Baxter INTRA VIA Container Recalled for Particulate Matter in Fluid Path

    Baxter Healthcare is recalling 20,448 units of INTRA VIA containers due to particulate matter found inside the fluid path.

    Product
    Baxter 2B8013 Empty INTRA VIA Container with PVC Ports (Sterile, nonpyrogenic fluid path) ,500 ml. Admixture Products and Accessories The lntraVia Empty Plastic Container is intended for use in the preparation and administration of drug admixtures.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-0084-2015·2014-11-12

    Baxter INTRA VIA Container Recalled for Particulate Matter in Fluid Path

    Baxter Healthcare Corp is recalling 94,224 INTRA VIA containers due to particulate matter found inside the fluid path.

    Product
    Baxter 2B8011 Empty INTRA VIA Container with PVC Ports, Sterile fluid path, 150 ml, Admixture Products and Accessories. The lntraVia Empty Plastic Container is intended for use in the preparation and administration of drug admixtures.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0020-2015·2014-10-22

    Hospira Recalls Lidocaine Hydrochloride Vials Due to Particulate Matter

    Hospira is recalling 109,110 vials of Lidocaine Hydrochloride Injection because the product was discolored and contained visible particulates.

    Product
    LIDOCAINE HYDROCHLORIDE — LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-1610-2014·2014-10-08

    Baxter Recalls Dianeal Low Calcium Peritoneal Dialysis Solution Bags

    Baxter Healthcare is recalling 50,530 bags of Dianeal Low Calcium peritoneal dialysis solution due to the presence of particulate matter found during manufacturing.

    Product
    DIANEAL LOW CALCIUM WITH DEXTROSE — DIANEAL LOW CALCIUM WITH DEXTROSE (SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0002-2015·2014-10-08

    Hospira Recalls Marcaine Injection Vials Due to Visible Metal Particles

    Hospira is recalling 40,730 vials of Marcaine (bupivacaine hydrochloride) injection because of a confirmed complaint of visible metal particles in the solution.

    Product
    MARCAINE — MARCAINE (BUPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide